CCL Products Exercises 319 Employee Stock Options Under 2022 Scheme
CCL Products (India) Limited announced the exercise of 319 equity shares under its Employee Stock Option Scheme 2022 by an eligible employee on March 18, 2026. The shares were issued at face value of Rs. 2/- with no premium, transferred from CCL Employees Trust, and will rank pari-passu with existing shares without affecting the company's paid-up share capital.
*this image is generated using AI for illustrative purposes only.
CCL Products (India) Limited has announced the exercise of 319 equity shares under its Employee Stock Option Scheme 2022, marking another milestone in the company's employee benefit initiatives. The exercise was completed by an eligible employee on March 18, 2026, following the completion of the applicable vesting period as per the official regulatory filing.
ESOP Exercise Details
The company has provided comprehensive details regarding the stock option exercise in compliance with SEBI regulations. The shares were transferred from the CCL Employees Trust, which was established specifically for implementing the employee stock option scheme.
| Parameter: | Details |
|---|---|
| Number of Shares Exercised: | 319 |
| Exercise Date: | March 18, 2026 |
| Exercise Price per Share: | Rs. 2/- |
| Face Value per Share: | Rs. 2/- |
| Premium per Share: | Nil |
| Distinctive Numbers: | 133198038 to 133198356 |
| ISIN Number: | INE421D01022 |
Share Capital Impact
The company has clarified that this exercise does not result in any change to its paid-up share capital. The allotted shares will rank pari-passu with the existing shares of the company, ensuring equal rights and privileges for all shareholders.
| Share Capital Details: | Amount/Number |
|---|---|
| Total Issued Shares After Exercise: | 13,35,27,920 |
| Total Issued Share Capital: | Rs. 26,70,55,840/- |
| Share Denomination: | Rs. 2/- each |
| Lock-in Period: | Not applicable |
Regulatory Compliance
The disclosure has been made pursuant to Regulation 10 of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has filed the necessary documentation with both NSE and BSE, maintaining transparency with the stock exchanges.
Key compliance aspects include:
- Shares issued in demat form with no physical certificates
- No lock-in period applicable to the exercised shares
- Shares identical in all respects to existing equity shares
- No additional listing fees payable
Scheme Background
The CCL Employee Stock Option Scheme 2022 was previously filed with the stock exchanges in two tranches. The initial filing for 4,00,000 shares was completed in September 2022, followed by an additional filing for 1,00,000 shares in February 2024.
| Filing Details: | NSE | BSE |
|---|---|---|
| First Tranche (4,00,000 shares): | September 23, 2022 | September 22, 2022 |
| Second Tranche (1,00,000 shares): | February 9, 2024 | February 9, 2024 |
| Filing Numbers (First): | NSE/LIST/32675 | DCS/IPO/MJ/ESOPIP/2501/2022-23 |
| Filing Numbers (Second): | NSE/LIST/39980 | DCS/IPO/JP/ESOPIP/3107/2023-24 |
This systematic approach demonstrates the company's commitment to structured employee benefit programs and regulatory compliance. The shares are listed on both National Stock Exchange of India Limited and BSE Limited, with scrip codes CCL and 519600 respectively.
Historical Stock Returns for CCL Products
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.42% | -3.00% | +2.99% | +22.45% | +85.85% | +353.39% |
How many shares remain unexercised under CCL's ESOP 2022 scheme and what is the expected timeline for future exercises?
Will CCL Products consider expanding its employee stock option program beyond the current 5 lakh shares allocated across both tranches?
What impact might increased employee ownership through ESOP exercises have on CCL's talent retention and recruitment strategy in the competitive coffee industry?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
